TD

(redirected from travelers' diarrhea)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

TD

The two-character ISO 3166 country code for CHAD.

TD

1. ISO 3166-1 alpha-2 code for the Republic of Chad. This is the code used in international transactions to and from bank accounts in Chad.

2. ISO 3166-2 geocode for Chad. This is used as an international standard for shipping to Chad. Each region in Chad has its own code with the prefix "TD." For example, the code for the Region of Batha is ISO 3166-2:TD-BA.
References in periodicals archive ?
Such forward-looking statements include statements about IOMAI 's ability to stimulate stronger immune responses, ease of application and tolerability of the dry patches and the estimated size of the travelers' diarrhea market.
A common infection of the intestine is travelers' diarrhea, which is primarily caused by the ingestion of food or water contaminated by pathogenic strains of bacteria.
Although not statistically significant, the frequency of new-onset irritable bowel syndrome, a long-term consequence of travelers' diarrhea, was three times greater in placebo than vaccine recipients.
Rifamycin SV MMX is a broad spectrum, semi-synthetic antibiotic with negligible systemic absorption, which is being developed for the treatment of patients with travelers' diarrhea and potentially for other diseases that have an infectious component in the colon.
The filing of the IND is an important milestone in the rifamycin SV MMX clinical program, and we look forward to moving forward with the development of rifamycin SV MMX for patients with travelers' diarrhea," said Gerald T.
Such forward-looking statements include statements that Iomai will successfully commercialize its travelers' diarrhea vaccine patch; that such vaccine would be approved with self-application of any dose; statements about Iomai's plans to initiate a Phase 3 study in the summer of 2009 and the potential size of the market for a travelers' diarrhea vaccine; and that, if approved, Iomai's vaccine would be the first available in the U.
Such forward-looking statements include statements about the ability of Iomai's patch vaccine to prevent travelers' diarrhea; expected government funding; sufficiency of existing cash and government contract revenues to fund operations into the second half of 2008; timing and expectation for initiating new clinical trials and completing and reporting results on Iomai's clinical trials, including follow-on Phase 2 and Phase 3 studies on the travelers' diarrhea product candidate, and Phase 1/2 study for pandemic flu dose-sparing adjuvant.
The bacterial causes of travelers' diarrhea exact a toll not only on travelers, but also on those who live in areas in which those bacteria are endemic.
18 /PRNewswire-FirstCall/ -- Iomai Corporation today announced that travelers who received the company's patch-based travelers' diarrhea vaccine were significantly less likely to be sickened as compared with travelers who receive a placebo, according to research presented today by Chief Scientific Officer Gregory Glenn, M.
23 /PRNewswire-FirstCall/ -- Iomai Corporation today announced that the abstract detailing efficacy and safety results from its double-blind Phase 2 field study of a patch-based vaccine for travelers' diarrhea has been accepted as a "late breaker" presentation at Interscience Conference on Antimicrobials and Chemotherapy (ICAAC), to be held in Chicago Sept.
Travelers' diarrhea is infectious diarrhea caused by bacteria, viruses or parasites and is contracted by the ingestion of contaminated food or water.
This quarter was marked by a series of important clinical findings about our patch-based vaccines for travelers' diarrhea and influenza.